Article
Patients' Preferences for Attributes of Molecular Targeting Therapies for Advanced Non-Small Cell Lung Cancer with EGFR Mutations in Japan-A Discrete-Choice Experiment.
Gan to kagaku ryoho. Cancer & chemotherapy - 1 Dec 2022
Nakagawa Kazuhiko, Tanizawa Yoshinori, Cai Zhihong, Matsui Tomoko, Enatsu Sotaro
Abstract excerpt
AIM: This study aims to evaluate Japanese patients' preferences in first-line therapy choice for advanced non-small cell lung cancer(NSCLC)with epidermal growth factor receptor(EGFR)mutations. METHODS: A cross-sectional discrete-choice experiment was conducted on advanced NSCLC patients in Japan. Participants completed the online questionnaire that included different levels of 5 treatment attributes: time to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
